▶ 調査レポート

ビタミンDサプリメントの世界市場:タイプ別(ビタミンD2(エルゴカルシフェロール)、ビタミンD3(コレカルシフェロール)、用途別(機能性食品・飲料、ニュートリコスメティクス、動物用栄養)、地域別分析

• 英文タイトル:Global Vitamin D Supplements Market - Growth, Trends and Forecasts (2018 - 2023)

Mordor Intelligenceが調査・発行した産業分析レポートです。ビタミンDサプリメントの世界市場:タイプ別(ビタミンD2(エルゴカルシフェロール)、ビタミンD3(コレカルシフェロール)、用途別(機能性食品・飲料、ニュートリコスメティクス、動物用栄養)、地域別分析 / Global Vitamin D Supplements Market - Growth, Trends and Forecasts (2018 - 2023) / B-MOR-040557資料のイメージです。• レポートコード:B-MOR-040557
• 出版社/出版日:Mordor Intelligence / 2018年3月
• レポート形態:英文、PDF、120ページ
• 納品方法:Eメール(受注後2営業日)
• 産業分類:食品・飲料
• 販売価格(消費税別)
  Single User(1名様用)¥454,750 (USD4,250)▷ お問い合わせ
  Team User(7名様用)¥481,500 (USD4,500)▷ お問い合わせ
  Corporate User¥936,250 (USD8,750)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本資料は、ビタミンDサプリメントの世界市場について調べ、ビタミンDサプリメントの世界規模、市場動向、市場環境、タイプ別(ビタミンD2(エルゴカルシフェロール)、ビタミンD3(コレカルシフェロール)分析、用途別(機能性食品・飲料、ニュートリコスメティクス、動物用栄養)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、中国市場規模、企業の競争環境、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・ビタミンDサプリメントの世界市場インサイト
・ビタミンDサプリメントの世界市場環境
・ビタミンDサプリメントの世界市場動向
・ビタミンDサプリメントの世界市場規模
・ビタミンDサプリメントの世界市場規模:タイプ別(ビタミンD2(エルゴカルシフェロール)、ビタミンD3(コレカルシフェロール)
・ビタミンDサプリメントの世界市場規模:用途別(機能性食品・飲料、ニュートリコスメティクス、動物用栄養)
・ビタミンDサプリメントの世界市場:地域別市場規模・分析
・ビタミンDサプリメントの北米市場規模・予測
・ビタミンDサプリメントのアメリカ市場規模・予測
・ビタミンDサプリメントのヨーロッパ市場規模・予測
・ビタミンDサプリメントのアジア市場規模・予測
・ビタミンDサプリメントの中国市場規模・予測
・ビタミンDサプリメントのインド市場規模・予測
・関連企業情報・競争状況

Vitamin D is a fat-soluble, “sunshine” vitamin that is naturally present in very few food. Vitamin D performs a multi-functional role in the human body. It is called the sunshine vitamin, as the human body produces it when the skin is exposed to the sun’s ultraviolet rays. Vitamin D supplements are increasingly recommended to children, especially due its deficiency, and also because it performs a host of physiological functions. It is required for proper absorption of calcium and phosphorus by the intestinal tract. It is required for normal growth and development of bones and teeth, protection against muscle weakness, and regulation of the heart. Vitamin D promotes calcium absorption in the gut, and maintains adequate serum calcium and phosphate concentrations, to enable normal mineralization of bone and to prevent hypocalcemic tetany.
It has been widely accepted that vitamin D deficiency (VDD) is a global health problem that impacts not only musculoskeletal health but also cause acute and chronic diseases. It is, thus, in the context of the global scenario, vitamin D is widely available as a dietary supplement.

Market Dynamics

Dietary supplements are continuously evolving, in order to cater to the niche population segments (pregnant and breast-feeding women, geriatric, and pediatric nutrition) and due to intensive fortification initiatives undertaken by governments, the world over. The increasing awareness related to vitamin supplements has led to favorable sentiments toward the vitamin supplements market.
The global vitamin D supplements market is expected to register exponential growth, with a double-digit CAGR of 12.4% during the forecast period (2018–2023), due to the hectic lifestyle, increasing health consciousness, evolving dietary patterns, and the increasing demand for vitamin supplements, in the backdrop of emerging cases of micronutrient deficiencies.

Market Segmentation

The global vitamin D supplements market is segmented based on type, application, and geography. Under supplements and fortified foods, vitamin D is available in two forms – D2 (ergocalciferol) and D3 (cholecalciferol) that are molecularly different. The two forms have traditionally been regarded as equivalent, based on their ability to cure rickets (weakening of bones, due to extreme and prolonged vitamin D deficiency). The vitamin D2 (ergocalciferol) segment is expected to grow at a higher rate comparatively, as it is available from non-animal sources (fungi and plants) as opposed to vitamin D3 (cholecalciferol), which is animal-derived. However, most studies have found that vitamin D2 is much less potent than D3 in raising the level of vitamin D in the blood stream.

Regional Analysis

Asia-Pacific is projected to be the fastest-growing market for vitamin D supplements, due to the increasing consumer awareness regarding vitamin D deficiency, and growing incidences of diseases, such as osteoporosis, osteomalacia, and rickets, in countries, such as India and China. In India, as food fortification is deficient, supplementing with pharmaceutical preparations is the only means of treatment of vitamin D deficiency. However, due to lack of awareness regarding the daily recommended dosage, there is a need for marketing and rational prescribing of the appropriate vitamin D supplement in the Asia-Pacific region.

MAJOR PLAYERS: ABBOTT LABORATORIES, NESTLE SA, DM ALLIANCE NUTRITION, INC., FERMENTA BIOTECH LTD., KRAFT FOODS GROUP, INC., SYNTHESIA, AS., PFIZER, INC., KONINKLIJKE DSM NV, GROUPE DANONE S.A., and ARCHER DANIELS MIDLAND COMPANY, amongst others.

Recent Industry Insights:

“Researchers from Medical College of Georgia at University of Augusta have quoted, based on randomized trials that large dosage of vitamin D rapidly reduces arterial stiffness.”
“The US-based Pure Mountain Botanicals launched a new product – 5000 IU Vitamin D3 Drops that can be conveniently consumed with juice, water, or any beverage.”

Reasons to Purchase this report

• Market outlook, with the recent trends and Porter’s five forces analysis
• Market dynamics considering the factors that impel the present market scenario, along with the market growth opportunities in the years to come
• Market segmentation analysis, including qualitative and quantitative research, incorporating the impact of economic and non-economic aspects
• Country-level analysis, integrating the demand and supply forces that are influencing the market growth
• Competitive landscape incorporating the market share of major players, along with the key strategies that were adopted by them in the past five years
• Comprehensive company profiles, covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies that are employed by the major market players
• 3 months analyst support, along with the Market Estimate sheet (in excel).

Customization of the Report

• This report can be customized to meet your requirements. Please connect with our analyst, who will ensure you get a report that suits your needs

レポート目次

1. Introduction
1.1 Key Deliverables of the Study
1.2 Study Assumptions
1.3 Market Definitions
2. Research Approach and Methodology
2.1 Introduction
2.2 Research Design
2.3 Study Timelines
2.4 Study Phases
2.4.1 Secondary Research
2.4.2 Discussion Guide
2.4.3 Market Engineering & Econometric Modelling
2.4.4 Expert Validation
3. Market Overview
3.1 Drivers
3.1.1 Rising prevalence of vitamin deficiency diseases
3.1.2 Prevalence of bone diseases
3.2 Restraints
3.2.1 Regulatory environment
3.3 Opportunities
3.3.1 Government initiatives for fortification
3.3.2 Emerging economies – untapped potential
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of New Entrants
3.4.4 Threat of Substitute Products and Services
3.4.5 Degree of Competition
4. Market Segmentation
4.1 By Analog Type
4.1.1 Vitamin D2 (ergocalciferol)
4.1.2 Vitamin D3 (cholecalciferol)
4.2 By Application
4.2.1 Functional Food & Beverage
4.2.2 Nutricosmetics
4.2.3 Animal nutrition
4.3 By Geography
4.3.1 North America
4.3.1.1 United States
4.3.1.2 Canada
4.3.1.3 Mexico
4.3.1.4 Others
4.3.2 Europe
4.3.2.1 Spain
4.3.2.2 UK
4.3.2.3 France
4.3.2.4 Germany
4.3.2.5 Russia
4.3.2.6 Italy
4.3.2.7 Others
4.3.3 Asia-Pacific
4.3.3.1 China
4.3.3.2 India
4.3.3.3 Malaysia
4.3.3.4 Indonesia
4.3.3.5 Others
4.3.4 South America
4.3.4.1 Brazil
4.3.4.2 Argentina
4.3.4.3 Others
4.3.5 Africa
4.3.5.1 South Africa
4.3.5.2 Others
4.4 Competitive Landscape
4.4.1 Strategy adopted by Key players
4.4.2 Most Active Companies
4.4.3 Market Share Analysis
4.5 Company Profiles
4.5.1 Abbott Laboratories
4.5.2 Nestle SA
4.5.3 DM Alliance Nutrition, Inc.
4.5.4 Fermenta Biotech Ltd.
4.5.5 Kraft Foods Group, Inc.
4.5.6 Synthesia, AS.
4.5.7 Pfizer, Inc.
4.5.8 Koninklijke DSM NV
4.5.9 Groupe Danone S.A.
4.5.10 Archer Daniels Midland Company
4.6 Appendix